Growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more weight ...

Eli Lilly said on Thursday its next-generation obesity drug helped patients lose an average of 28.7% of their weight in a ...

Online telehealth company Hims and Hers Health is launching its weight-loss membership and treatment plans in the United ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

And one of them is pharmaceutical giant Pfizer ( PFE 0.04%). Now, with a major step along the path to entering this billion-dollar market, did Pfizer just say "checkmate" to Novo Nordisk? Let's find ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

The rise of weight loss drugs such as Ozempic and Wegovy has changed the way Americans eat and shop, along with how major ...

Healthify plans to expand partnerships with weight-loss drugmakers, leveraging its new deal with Novo Nordisk to enhance ...

Novo Nordisk's appeal is listed for hearing on Friday before a bench of Justice C Hari Shankar and Justice Om Prakash Shukla ...

Women with polycystic ovary syndrome (PCOS) are increasingly using GLP-1 weight-loss drugs from Eli Lilly and Novo Nordisk to ...

A next-generation obesity shot from Eli Lilly and Co. helped patients lose almost a quarter of their body weight, potentially ...

Eli Lilly (LLY) stock rises as analysts cheer Phase 3 trial data for the company's next-gen weight loss therapy, retatrutide.